Hangzhou Biotest Biotech Co.,Ltd. Stock
Equities
688767
CNE1000050H0
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.4 CNY | +2.08% | -4.92% | -2.87% |
Sales 2022 | 1.9B 263M | Sales 2023 | 442M 61.21M | Capitalization | 3.23B 447M |
---|---|---|---|---|---|
Net income 2022 | 774M 107M | Net income 2023 | 107M 14.81M | EV / Sales 2022 | 1.52 x |
Net cash position 2022 | 2.03B 281M | Net cash position 2023 | 1.9B 264M | EV / Sales 2023 | 3 x |
P/E ratio 2022 |
6.37
x | P/E ratio 2023 |
30.3
x | Employees | 730 |
Yield 2022 |
4.76% | Yield 2023 |
-
| Free-Float | 33.12% |
1 day | +2.08% | ||
1 week | -4.92% | ||
Current month | +2.65% | ||
1 month | +17.32% | ||
3 months | +16.21% | ||
6 months | -4.73% | ||
Current year | -2.87% |
Managers | Title | Age | Since |
---|---|---|---|
Shu Jiang Wu
CEO | Chief Executive Officer | 47 | 10-01-31 |
Miao Miao Yu
DFI | Director of Finance/CFO | 43 | 15-12-31 |
Dong Chen
CTO | Chief Tech/Sci/R&D Officer | 28 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yin Long Chen
CHM | Chairman | 62 | 15-09-27 |
Shu Jiang Wu
CEO | Chief Executive Officer | 47 | 10-01-31 |
Yu Jie Chen
BRD | Director/Board Member | 34 | 15-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 12 M€ | -16.71% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 29.4 | +2.08% | 549,543 |
24-05-16 | 28.8 | -0.24% | 481,316 |
24-05-15 | 28.87 | -1.77% | 601,559 |
24-05-14 | 29.39 | -0.34% | 789,977 |
24-05-13 | 29.49 | -4.62% | 1,427,300 |
End-of-day quote Shanghai S.E., May 16, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-2.87% | 426M | |
-4.67% | 12.32B | |
-5.19% | 8.07B | |
+9.45% | 5.91B | |
+28.50% | 5.52B | |
-8.09% | 4.21B | |
-55.31% | 2.99B | |
+13.49% | 2.73B | |
-1.34% | 2.43B | |
+32.24% | 2.29B |
- Stock Market
- Equities
- 688767 Stock